Breckenridge Pharmaceutical, Inc. is a privately-held member of the Esteve Group. We are an own label Distributor that performs pharmaceutical research and development as well as marketing and distribution in the U.S. The company was founded in 1983, and markets a broad range of generic prescription products in many therapeutic categories and dosage forms.
The Breckenridge label is recognized by Retail Pharmacy Chains, Mail Order Pharmacies, Pharmacy Benefit Managers, Managed Care Facilities, and Group Purchasing Organizations as well as Wholesalers and Distributors throughout the United States.
We market in excess of 70 products in a variety of dosage forms including: tablets, capsules, soft gel capsules, liquids, suspensions, ophthalmics, nasal sprays and powders. Our pipeline includes:Injectables, Transdermals, Inhalers and Topical products.
Breckenridge, with company offices in Boca Raton, FL - Berlin, CT and New York City - has 30 approved Abbreviated New Drug Applications (ANDA's) approved by the Food and Drug Administration (FDA). We also have over 80 products in our pipeline; including 25 that contain Paragraph IV patent challenges.
we create opportunity